Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 12, 2023
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
Ed Arce Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Sep 12th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $6 on, Sep 12th, 2023.
Ed has made no other calls on ABUS in the last 4 months.
There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $6 on, Friday, August 4th, 2023
- Roy Buchanan of "JMP Securities" Reiterated at Buy and Held Target at $6 on, Thursday, July 6th, 2023
